Patched Homolog Gene (PTCHI) As a Reliable Marker for Predicting Imatinib Response in Chronic Phase Chronic Myeloid Leukemia Patients in Correlation with Early Response to First - Egyptian Knowledge Bank

262203

Patched Homolog Gene (PTCHI) As a Reliable Marker for Predicting Imatinib Response in Chronic Phase Chronic Myeloid Leukemia Patients in Correlation with Early Response to First

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Study of PTCH1 Gene as a Prognostic Marker to Predict Imatinib Response in CML Patients: a Single Egyptian Center Experience

Article

Association of Microrna-153-3p Expression in Response to Treatment with Imatinib in Patients with Chronic Myeloid Leukemia

Article

Response of Chronic Myeloid Leukemia's Patient to Different Types of Tyrosine Kinase Inhibitors

Thesis

Assessment of Response of Chronic Phase CML to Imatinib treatment

Article

Serum Levels of Angiopoietin-2 and C-Reactive Protein in Chronic Myeloid Leukaemia Patients: Relation to Different Phases of the Disease

Article

NILOTINIB VS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA-CHRONIC PHASE

Thesis

The relation between multidrug resistance gene (MDR1) polymorphism and response to tyrosine kinase inhibitors (TKIS) in patients with chronic myeloid leukemia (CML)

Thesis

Bcr – Abl mutations in chronic myeloid leukemia

Article

Correlation of Some Apoptotic Markers with Chronic Myelogenous Leukemia in Iraqi Patients

Article

Detection of C-kit gene Mutation in Patients with Acute Myeloid Leukemia